男友太凶猛1v1高h,大地资源在线资源免费观看 ,人妻少妇精品视频二区,极度sm残忍bdsm变态

USEUROPEAFRICAASIA 中文雙語Fran?ais
Business
Home / Business / Industries

Foreign interest grows in aging society

By LIU JIE | China Daily | Updated: 2013-03-30 01:56

Foreign interest grows in aging society

World headquarters of Pfizer Inc in New York.Provided to China Daily

Liu Zhanglin has been working in China's pharmaceutical industry — especially the consumer healthcare and traditional Chinese medicine segments — for nearly three decades.

The industry veteran forecasts the nation's consumer healthcare sector will grow at a steady 10 percent over the next three to five years.

Bruce Liu, a strategy consultant with equally rich experience in the international pharmaceutical industry, is even more optimistic.

He suggests that by 2015, the sector will be worth more than 100 billion yuan ($16.01 billion) from its current 60 billion yuan, and will be growing at around 20 percent annually.

But both professionals share one view — that the sector is likely to become one of China's most lucrative.

Liu Zhanglin, vice-president of China Chamber of Commerce for Import & Export of Medicines & Health Products, is slightly more conservative with his growth forecasts, but predicts the sector will accelerate at a higher rate than the nation's GDP growth, given the country's aging population.

Bruce Liu, a partner and co-head of the pharma and healthcare practice at Roland Berger Strategy Consultants, said one of the most striking aspects of China's fast-growing consumer healthcare sector is the number of multinational pharmaceutical companies competing in an attempt to cash in on market.

Pfizer Inc, the world's largest drugmaker by sales, for instance, announced at the end of January that it planned to target the China healthcare market with launch of a new supplement series.

"Pronutrients" is an advanced line of Pfizer's famous multivitamin brand "Centrum" and has been promoted to China only after its launch in the home market, the United States.

Pfizer now has several mature supplement brands in China, another being "Caltrate".

Related Readings

'Best time' to invest in healthcare industry

Healthcare reform improves equal access

Looking abroad for healthcare

China becoming healthcare R&D hub

Previous Page 1 2 3 4 5 Next Page

Most Viewed in 24 Hours
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 翼城县| 怀集县| 平阴县| 德令哈市| 韶山市| 益阳市| 芜湖市| 汉中市| 澄迈县| 楚雄市| 荆州市| 靖远县| 永康市| 永川市| 陇川县| 博乐市| 平湖市| 濉溪县| 宜春市| 肇州县| 涿州市| 孟村| 文昌市| 客服| 墨竹工卡县| 扶风县| 万载县| 湾仔区| 公安县| 民丰县| 泉州市| 绥阳县| 策勒县| 肃宁县| 玉环县| 南城县| 南川市| 北辰区| 武汉市| 基隆市| 革吉县|